Kaneka to Manufacture and Supply Intermediates for Shionogi COVID-19 Drug
29 Nov 2022 //
BUSINESSWIRE
Kaneka Eurogentec Announces Successful Production of 25g of mRNA in One Batch
22 Feb 2022 //
BUSINESSWIRE
29 Nov 2022 //
BUSINESSWIRE
22 Feb 2022 //
BUSINESSWIRE